We collected information about Jounce Therapeutics Inc Hours for you. Follow the liks to find out everything about Jounce Therapeutics Inc Hours.
Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge, MA 02139 Phone: (857) 259-3840 Fax: (888) 459-2940
https://www.nasdaq.com/market-activity/stocks/jnce/after-hours
Jounce Therapeutics, Inc. Common Stock (JNCE) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://jouncetx.com/about/
Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge, MA 02139 Phone: (857) 259-3840 Fax: (888) 459-2940. For Investor and Media inquiries, please contact: Eric Laub (857) 259-3853
https://finance.yahoo.com/quote/JNCE/
Find the latest Jounce Therapeutics, Inc. (JNCE) stock quote, history, news and other vital information to help you with your stock trading and investing. ... U.S. markets open in 9 hours. S&P ...
https://www.marketwatch.com/investing/Stock/JNCE
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to ...
https://www.barrons.com/market-data/stocks/JNCE?countrycode=US
After Hours Vol. 1.36K. Price at close $8.70-0.09-1.02%. Nov 12, 2021 4:00 p.m. EST. About Jounce Therapeutics Inc. ... Complete Jounce Therapeutics Inc. stock information by …
https://www.marketwatch.com/investing/stock/jnce/financials/secfilings?docid=15326947
Jounce Therapeutics will host a live conference call and webcast today at 8:00 a.m. ET. To access the conference call, please dial (866) 916-3380 (domestic) or (210) 874-7772 (international) and ...
https://www.cnbc.com/quotes/JNCE
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing …
https://www.nasdaq.com/articles/jounce-therapeutics-inc-jnce-q3-2021-earnings-call-transcript-2021-11-06
Thank you, operator. This is Eric Laub, Vice President of Investor Relations at Jounce Therapeutics. Good morning, and welcome to the Jounce Therapeutics Third …
https://clinicaltrials.gov/ct2/show/NCT04549025
Jounce Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT04549025 Other Study ID Numbers: JTX-4014-202 : First Posted: September 16, 2020 Key Record Dates: Last Update Posted: October 5, 2021 Last Verified: October 2021
Searching for Jounce Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
